GLP-1 drugs, initially for diabetes, are revolutionizing medicine with weight-loss, lipid-lowering, and anti-inflammatory effects. Approved for obesity, cardiovascular disease, and kidney issues, they may soon treat...
Until now, in the field of anti-obesity treatments, there was a drug that attracted attention: Ozempic. It is also made by Novo Nordisk and is very...